Max Zeller Soehne AG
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Feasibility Study on the Use of Redormin®500 on Day-time Cognition (NCT05684523) | Max Zeller Soehne AG | 2023-03-01 |
| Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117 (NCT03482817) | Max Zeller Soehne AG | 2018-02-05 |
| Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117 (NCT02505191) | Max Zeller Soehne AG | 2015-11-01 |
| Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress (NCT02189239) | Max Zeller Soehne AG | 2015-01-01 |
| Investigation of Efficacy and Safety of EPOGAM (NCT00878670) | Max Zeller Soehne AG | 2009-03-01 |
| MOA Study of Ze 339 in Seasonal Allergic Rhinitis (NCT00862225) | Max Zeller Soehne AG | 2008-01-01 |
Track Max Zeller Soehne AG automatically
Every clearance here is in the API, with alerts when new ones post.